Nachrichten zur AstraZeneca PLC Aktie

Is Recursion Pharmaceuticals Stock a Millionaire Maker?

Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…

Beijing Woos AstraZeneca for Investment While Probe Continues

Beijing’s mayor called on AstraZeneca Plc to expand its research and development investment in the Chinese capital, signaling that a…

Why Astrazeneca (AZN) Outpaced the Stock Market Today

Astrazeneca (AZN) closed at $65.35 in the latest trading session, marking a +1.41% move from the prior day.…

PRESSESPIEGEL/Unternehmen: THYSSENKRUPP, SCHAEFFLER, TESLA, LILIUM, DM, ASTRAZENECA

DJ PRESSESPIEGEL/Unternehmen Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires. THYSSENKRUPP - Der Industriekonzern Thyssenkrupp hat eine…

AstraZeneca announces board refresh with new directors By Investing.com

AstraZeneca announces board refresh with new directors…

AstraZeneca names new non-executive directors By Investing.com

AstraZeneca names new non-executive directors…

Could IonQ Be Your Ticket to Becoming a Millionaire by 2035?

Finding a company that can make you a millionaire from a modest investment is rare. However, they are out there…

3 Unstoppable Stocks to Buy Right Now

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business fundamentals. Three Motley Fool contributors…

AstraZeneca (AZN) Shares Fall After Reports of PRC Probe Alleged Fraud and Corruption – Hagens Berman

SAN FRANCISCO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- AstraZeneca PLC (NASDAQ: AZN) is facing a significant crisis in…

50 Companies to Watch in 2025

From AstraZeneca to Vodacom, keep an eye on these global stocks this year.…

Better Quantum Computing Stock: Rigetti Computing vs. IonQ, Inc.

The quantum computing industry has emerged as one of 2024s hottest investing themes, with leading players seeing their stocks surge…

AZN, Daiichis ADC Gets FDA Breakthrough Tag for EGFR-Mutated NSCLC

The FDA bestows a Breakthrough Therapy designation to AstraZeneca and Daiichi Sankyos Dato-DXd for previously treated advanced EGFR-mutated NSCLC.…

2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer

Whether youre looking for a way to beat the benchmark S&P 500 index or you just want a steady flow…

Imfinzi approved in US for limited-stage SCLC

5 December 2024 Imfinzi approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer Based on…

AstraZenecas Imfinzi Gets FDA Nod for Expanded Use in SCLC

The FDA approves AZNs Imfinzi for treating patients with limited-stage small-cell lung cancer based on phase III ADRIATIC study data.…

Erkrankung nach Corona-Impfung - Gericht fordert Gutachten

BAMBERG (dpa-AFX) - Im Prozess gegen den Pharmakonzern Astrazeneca um einen möglichen Corona-Impfschaden hat eine Frau aus Oberfranken einen…

Erkrankung nach Corona-Impfung - Gericht fordert Gutachten

BAMBERG (dpa-AFX) - Im Prozess gegen den Pharmakonzern Astrazeneca um einen möglichen Corona-Impfschaden hat eine…

AstraZeneca appoints Iskra Reic EVP International

4 December 2024 AstraZeneca appoints Iskra Reic as Executive Vice President, International AstraZeneca today announced the appointment of Iskra Reic as Executive…

FTSE 100 Live: AstraZeneca leads decline, L&G surges, Wall Street opens higher

FTSE 100 drops 14 points London stock market exodus worsens Rio Tinto faces activist pressure 2..49pm: Wall Street opens higher…

FTSE 100 on its own in the red as AstraZeneca slumps, L&G surges on annuity boost

FTSE 100 drops 18 points London stock market exodus worsens Rio Tinto faces activist pressure 4.05pm: FTSE still on its…

FTSE 100 Live: AstraZeneca leads decline, L&G surges on annuity update

FTSE 100 drops 30 points European markets higher, ahead of French no-confidence vote Rio Tinto faces activist pressure 10.04am: Festive petrol…

FTSE 100 rally gathers momentum as heavyweights lift index

The FTSE 100 soared on Tuesday in a broad rally driven by London’s heavyweight stocks including Shell, AstraZeneca, and HSBC.…

Novo Nordisk and AstraZeneca top of the 2025 drug picks for US investment bank

Success in 2025 for the pharma sector will hinge on the success of key drug pipeline developments, according to JPMorgan’s latest…

Novo Nordisk and AstraZeneca top 2025 drug picks for US investment bank

Success in 2025 for the pharma sector will hinge on the success of key drug pipeline developments, according to JPMorgan’s latest…

AstraZeneca Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Das…

JPMorgan belässt Astrazeneca auf Overweight - Ziel 14000 Pence

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Das…

Total Voting Rights

2 December 2024 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

Top Stock Reports for Chevron, AstraZeneca & Arista Networks

Todays Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), AstraZeneca PLC (AZN) and Arista…

AstraZeneca cancer drug Enhertu added for reimbursement in China despite probe

…

2 Incredible Growth Stocks I Cant Stop Buying

Ground-floor opportunities in transformative technologies dont come along often. Were in a unique moment in which two revolutionary sectors --…

AstraZeneca: Enhertu wird in Chinas staatliche Krankenversicherung aufgenommen - Aktiennews

Bad Marienberg (www.aktiencheck.de) - Laut Reuters hat AstraZeneca (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London Stock Exchange-Symbol: AZN), ein führender…

AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe

China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance amid an ongoing probe into its…

AstraZenecas Combination Therapy Meets Goal in Prostate Cancer Study

Data from a late-stage study shows that treatment with a three-drug combo involving AZNs Truqap benefits patients with an aggressive…

AstraZeneca reports positive Phase 3 results for Truqap in prostate cancer

…

Truqap improved rPFS in advanced prostate cancer

25 November 2024 Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progression-free survival in CAPItello-281 Phase III trial First…

Is This Outstanding Index ETF a Millionaire-Maker?

Theres nothing wrong with keeping things simple. Consider, for example, how a recipe can be ruined by straying too far…

3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now

There are plenty of growth stocks trading at obscenely high valuations right now. Part of the reason for that is…

AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades

AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its…

NATIONAL UNIVERSITY HEALTH SYSTEM, SAHLGRENSKA UNIVERSITY HOSPITAL AND INDUSTRY PARTNERS, ASTRAZENECA AND ERICSSON ESTABLISH GLOBAL HEALTH INNOVATION NETWORK

20 November 2024 SINGAPORE — The National University Health System (NUHS) and Sahlgrenska University Hospital have formed a strategic partnership with…

dpa-AFX ProFeed